Vol 79, Supp. III (2021): Zeszyty Edukacyjne 3/2021
Opinie i stanowiska ekspertów
Get Citation

Kompleksowa rehabilitacja kardiologiczna podstawą prewencji wtórnej chorób układu sercowo-naczyniowego. Opinia ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego

Anna Jegier1, Dominika Szalewska2, Agnieszka Mawlichanów3, Tadeusz Bednarczyk4, Zbigniew Eysymontt5, Michał Gałaszek5, Artur Mamcarz6, Anna Mierzyńska78, Ewa Piotrowicz9, Ryszard Piotrowicz710, Krzysztof Smarż11, Edyta Smolis-Bąk7, Ewa Straburzyńska-Migaj12, Jadwiga Wolszakiewicz7
Affiliations
  1. Zakład Medycyny Sportowej, Uniwersytet Medyczny w Łodzi; Ośrodek Rehabilitacji Dziennej Centralnego Szpitala Klinicznego Uniwersytetu Medycznego w Łodzi
  2. Klinika Rehabilitacji, Wydział Nauk o Zdrowiu, Gdański Uniwersytet Medyczny
  3. Oddział Rehabilitacji Kardiologicznej, Szpital Specjalistyczny im. Jana Pawła II, Kraków
  4. Oddział Rehabilitacji Kardiologicznej, Kliniczny Szpital Wojewódzki nr 2 w Rzeszowie
  5. Śląskie Centrum Rehabilitacji i Prewencji w Ustroniu
  6. III Klinika Chorób Wewnętrznych i Kardiologii, Warszawski Uniwersytet Medyczny
  7. Klinika Choroby Wieńcowej i Rehabilitacji Kardiologicznej, Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego — Państwowy Instytut Badawczy, Warszawa
  8. Klinika Rehabilitacji, Centrum Medyczne Kształcenia Podyplomowego, Samodzielny Publiczny Szpital Kliniczny im. prof. Adama Grucy, Otwock
  9. Centrum Telekardiologii, Narodowy Instytut Kardiologii Stefana Kardynała Wyszyńskiego — Państwowy Instytut Badawczy, Warszawa
  10. Wyższa Szkoła Rehabilitacji w Warszawie
  11. Klinika Kardiologii, Centrum Medyczne Kształcenia Podyplomowego, Szpital Grochowski, Warszawa
  12. I Klinika i Katedra Kardiologii, Uniwersytet Medyczny w Poznaniu, Szpital Kliniczny Przemienienia Pańskiego, Poznań

paid access

Vol 79, Supp. III (2021): Zeszyty Edukacyjne 3/2021
Zeszyty edukacyjne

Abstract

Kompleksowa rehabilitacja kardiologiczna (CR) jest podstawą wtórnej prewencji chorób układu sercowo-naczyniowego (CVD). W wytycznych Europejskiego Towarzystwa Kardiologicznego CR ma najwyższą klasę zaleceń i najwyższy poziom wiarygodności danych naukowych jako skuteczna metoda leczenia chorych z zawałem serca z uniesieniem odcinka ST, po rewaskularyzacji mięśnia sercowego, z przewlekłym zespołem wieńcowym, stosowana w profilaktyce CVD w praktyce klinicznej oraz u osób z niewydolnością serca. Niniejszy dokument przedstawia opinię ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego dotyczącą korzyści z CR, grup docelowych, wskazań klinicznych, organizacji świadczeń rehabilitacyjnych i sposobów ich realizacji. W opracowaniu przedstawiono również psychospołeczne czynniki ryzyka wpływające na przebieg CR oraz prewencję wtórną CVD u chorych poddawanych CR. Kompleksowa CR to proces, który powinien zostać wdrożony jak najszybciej, być kontynuowany bez przerwy i składać się z wielu etapów. Ponadto CR powinna być dostosowana do indywidualnej sytuacji klinicznej i akceptowana przez chorego oraz jego rodzinę, przyjaciół i opiekunów.

Abstract

Kompleksowa rehabilitacja kardiologiczna (CR) jest podstawą wtórnej prewencji chorób układu sercowo-naczyniowego (CVD). W wytycznych Europejskiego Towarzystwa Kardiologicznego CR ma najwyższą klasę zaleceń i najwyższy poziom wiarygodności danych naukowych jako skuteczna metoda leczenia chorych z zawałem serca z uniesieniem odcinka ST, po rewaskularyzacji mięśnia sercowego, z przewlekłym zespołem wieńcowym, stosowana w profilaktyce CVD w praktyce klinicznej oraz u osób z niewydolnością serca. Niniejszy dokument przedstawia opinię ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego dotyczącą korzyści z CR, grup docelowych, wskazań klinicznych, organizacji świadczeń rehabilitacyjnych i sposobów ich realizacji. W opracowaniu przedstawiono również psychospołeczne czynniki ryzyka wpływające na przebieg CR oraz prewencję wtórną CVD u chorych poddawanych CR. Kompleksowa CR to proces, który powinien zostać wdrożony jak najszybciej, być kontynuowany bez przerwy i składać się z wielu etapów. Ponadto CR powinna być dostosowana do indywidualnej sytuacji klinicznej i akceptowana przez chorego oraz jego rodzinę, przyjaciół i opiekunów.

Get Citation

Keywords

opinia ekspertów, rehabilitacja kardiologiczna, choroby układu sercowo-naczyniowego, prewencja wtórna CVD

About this article
Title

Kompleksowa rehabilitacja kardiologiczna podstawą prewencji wtórnej chorób układu sercowo-naczyniowego. Opinia ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 79, Supp. III (2021): Zeszyty Edukacyjne 3/2021

Article type

Opinie i stanowiska ekspertów

Pages

28-45

Keywords

opinia ekspertów
rehabilitacja kardiologiczna
choroby układu sercowo-naczyniowego
prewencja wtórna CVD

Authors

Anna Jegier
Dominika Szalewska
Agnieszka Mawlichanów
Tadeusz Bednarczyk
Zbigniew Eysymontt
Michał Gałaszek
Artur Mamcarz
Anna Mierzyńska
Ewa Piotrowicz
Ryszard Piotrowicz
Krzysztof Smarż
Edyta Smolis-Bąk
Ewa Straburzyńska-Migaj
Jadwiga Wolszakiewicz

References (104)
  1. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119–177.
  2. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165.
  3. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
  4. Piepoli MF, Hoes AW, Agewall S, et al. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–2381.
  5. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008; 10(10): 933–989.
  6. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
  7. Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(10): 1169–1186.
  8. Pelliccia A, Sharma S, Gati S, et al. ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021; 42(1): 17–96.
  9. Haykowsky M, Scott J, Esch B, et al. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling. Trials. 2011; 12: 92.
  10. Cowie A, Buckley J, Doherty P, et al. British Association for Cardiovascular Prevention and Rehabilitation (BACPR). Standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2019; 105(7): 510–515.
  11. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020 [Epub ahead of print]: 2047487320913379.
  12. Abreu A, Schmidt JP, Piepoli ME. ESC Handbook of cardiovascular rehabilitation: a practical clinical guide. Oxford University Press. 2020.
  13. Piotrowicz R, Jegier A, Szalewska D. Rekomendacje w zakresie realizacji kompleksowej rehabilitacji kardiologicznej. Stanowisko Ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego. AsteriaMed, Gdańsk 2017.
  14. Alter DA, Oh PI, Chong A. Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system. Eur J Cardiovasc Prev Rehabil. 2009; 16(1): 102–113.
  15. Rauch B, Davos CH, Doherty P, et al. ‘Cardiac Rehabilitation Section’, European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, and the Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, Düsseldorf, Germany. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies — The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol. 2016; 23(18): 1914–1939.
  16. Smarż K, Jaxa-Chamiec T, Bednarczyk T, et al. Electrocardiographic exercise testing in adults: performance and interpretation. An expert opinion of the Polish Cardiac Society Working Group on Cardiac Rehabilitation and Exercise Physiology. Kardiol Pol. 2019; 77(3): 399–408.
  17. Smarż K, Jaxa-Chamiec T, Chwyczko T, et al. Cardiopulmonary exercise testing in adult cardiology: expert opinion of the Working Group of Cardiac Rehabilitation and Exercise Physiology of the Polish Cardiac Society. Kardiol Pol. 2019; 77(7-8): 730–756.
  18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1): 111–117.
  19. Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol. 2017; 22(3): e12447.
  20. Lipiec P, Bąk J, Braksator W, et al. Transthoracic echocardiography in adults — guidelines of the Working Group on Echocardiography of the Polish Cardiac Society [article in Polish]. Kardiol Pol. 2018; 76(2): 488–493.
  21. Steeds RP, Garbi M, Cardim N, et al. 2014–2016 EACVI Scientific Documents Committee. EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review. Eur Heart J Cardiovasc Imaging. 2017; 18(11): 1191–1204.
  22. Gielen S, Laughlin MH, O'Conner C, et al. Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis. 2015; 57(4): 347–355.
  23. Smolis-Bak E, Kazimierska B. Fizjoterapia w kardiologii. Lapisart, Warszawa 2013.
  24. Piotrowicz R, Piotrowicz E. Telerehabilitacja. Tekst sp. z o.o., Warszawa 2011.
  25. Piotrowicz E. How to do: telerehabilitation in heart failure patients. Cardiol J. 2012; 19(3): 243–248.
  26. Piotrowicz E, Piepoli MF, Jaarsma T, et al. Telerehabilitation in heart failure patients: The evidence and the pitfalls. Int J Cardiol. 2016; 220: 408–413.
  27. Piotrowicz E, Pencina MJ, Opolski G, et al. Effects of a 9-week hybrid comprehensive telerehabilitation program on long-term outcomes in patients with heart failure: the telerehabilitation in heart failure patients (TELEREH-HF) randomized clinical trial. JAMA Cardiol. 2020; 5(3): 300–308.
  28. Piotrowicz E, Baranowski R, Bilinska M, et al. A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail. 2010; 12(2): 164–171.
  29. Piotrowicz E, Zieliński T, Bodalski R, et al. Home-based telemonitored nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study. Eur J Prev Cardiol. 2015; 22(11): 1368–1377.
  30. Piotrowicz E, Korzeniowska-Kubacka I, Chrapowicka A, et al. Feasibility of home-based cardiac telerehabilitation: results of TeleInterMed study. Cardiol J. 2014; 21(5): 539–546.
  31. Piotrowicz R, Krzesiński P, Balsam P, et al. Cardiology telemedicine solutions — opinion of the experts of the Committee of Informatics and Telemedicine of Polish Society of Cardiology, Section of Non-invasive Electrocardiology and Telemedicine of Polish Society of Cardiology and Clinical Sciences C [article in Polish]. Kardiol Pol. 2018; 76(3): 698–707.
  32. Jankowski P, Niewada M, Bochenek A, et al. Optimal model of comprehensive rehabilitation and secondary prevention [article in Polish]. Kardiol Pol. 2013; 71(9): 995–1003.
  33. Rozporządzenie ministra zdrowia z dnia 16 grudnia 2016 r. zmieniające rozporządzenie w sprawie świadczeń gwarantowanych z zakresu rehabilitacji leczniczej. Dz. U. 2016, poz. 2162.
  34. Jankowski P, Gąsior M, Gierlotka M, et al. Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System [article in Polish]. Kardiol Pol. 2016; 74(8): 800–811.
  35. Anderson L, Thompson DR, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016; 67(1): CD001800.
  36. de Vries H, Kemps HMC, van Engen-Verheul MM, et al. Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients. Eur Heart J. 2015; 36(24): 1519–1528.
  37. Ponikowski P, Voors AA, Anker SD, et al. Authors/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18(8): 891–975.
  38. Fletcher GF, Ades PA, Kligfield P, et al. American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013; 128(8): 873–934.
  39. Piepoli MF, Conraads V, Corrà U, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011; 13(4): 347–357.
  40. Mezzani A, Hamm LF, Jones AM, et al. European Association for Cardiovascular Prevention and Rehabilitation, American Association of Cardiovascular and Pulmonary Rehabilitation, Canadian Association of Cardiac Rehabilitation. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol. 2013; 20(3): 442–467.
  41. Adamopoulos S, Corrà U, Laoutaris ID, et al. Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(1): 3–13.
  42. Potapov EV, Antonides C, Crespo-Leiro MG, et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg. 2019; 56(2): 230–270.
  43. Kindermann M, Schwaab B, Finkler N, et al. Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure. Eur Heart J. 2002; 23(16): 1301–1308.
  44. Abreu A, Frederix I, Dendale P, et al. Secondary Prevention and Rehabilitation Section of EAPC, Secondary Prevention and Rehabilitation Section of EAPC Reviewers: Marco Ambrosetti. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2020 [Epub ahead of print]: 2047487320924912.
  45. Caimmi PP, Sabbatini M, Kapetanakis EI, et al. A randomized trial to assess the contribution of a novel thorax support vest (corset) in preventing mechanical complications of median sternotomy. Cardiol Ther. 2017; 6(1): 41–51.
  46. Sibilitz KL, Berg SK, Tang LH, et al. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2016; 3: CD010876.
  47. Ribeiro GS, Melo RD, Deresz LF, et al. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis. Eur J Prev Cardiol. 2017; 24(7): 688–697.
  48. Piepoli MF, Corrà U, Benzer W, et al. Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010; 17(1): 1–17.
  49. Kuch M, Janiszewski M, Mamcarz A. Rehabilitacja kardiologiczna. Medical Education, Warszawa 2014.
  50. Anderson L, Nguyen TT, Dall CH, et al. Exercise-based cardiac rehabilitation in heart transplant recipients. Cochrane Database Syst Rev. 2017; 4: CD012264.
  51. DuBois CM, Lopez OV, Beale EE, et al. Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: a systematic review. Int J Cardiol. 2015; 195: 265–280.
  52. Ladwig KH, Lederbogen F, Albus C, et al. Position paper on the importance of psychosocial factors in cardiology: update 2013. Ger Med Sci. 2014; 12: Doc09.
  53. Pogosova N, Saner H, Pedersen SS, et al. Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015; 22(10): 1290–1306.
  54. Mierzyńska A, Kowalska M, Stepnowska M, et al. Psychological support for patients following myocardial infarction. Cardiol J. 2010; 17(3): 319–324.
  55. Beniamini Y, Johnston M, Karademas EC. Assessment in health psychology. Hogrefe Publishing GmbH, Göttingen 2016.
  56. Diener E, Emmons RA, Larson RJ, Griffin S. Skala satysfakcji z życia SWLS. In: Juczyński Z. ed. Narzędzia do pomiaru w promocji i psychologii zdrowia. Pracownia Testów Psychologicznych PTP, Warszawa 2001: 134–138.
  57. Golicki D, Niewada M. EQ-5D-5L Polish population norms. Arch Med Sci. 2017; 13(1): 191–200.
  58. Höfer S, Lim L, Guyatt G, et al. The MacNew heart disease health-related quality of life instrument: a summary. Health Qual Life Outcomes. 2004; 2: 3.
  59. Kokoszka A, Jastrzębski A, Obrębski M. Psychometric properties of the polish version of Patient Health Questionnaire-9 [article in Polish]. Psychiatria. 2016; 13(4): 187–193.
  60. Łojek E, Wójcik E, Stańczak J. Kwestionariusz do pomiaru depresji. Podręcznik. Pracownia Testów Psychologicznych PTP, Warszawa 2015.
  61. Makowska Z, Merecz D. Ocena zdrowia psychicznego na podstawie badań kwestionariuszami Davida Goldberga. Wydawnictwo Instytutu Medycyny Pracy, Łódź 2001.
  62. Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015; 91(9): 617–624.
  63. Juczyński Z, Ogińska-Bulik N. Narzędzia pomiaru stresu i radzenia sobie ze stresem. Pracownia Testów Psychologicznych PTP, Warszawa 2010.
  64. Strelau J, Jaworowska A, Wrześniewski K, Szczepaniak P. Kwestionariusz radzenia sobie w sytuacjach stresowych CISS. Podręcznik. Pracownia Testów Psychologicznych PTP, Warszawa 2005.
  65. Uchmanowicz I, Wleklik M. Polish adaptation and reliability testing of the nine-item European Heart Failure Self-care Behaviour Scale (9-EHFScBS). Kardiol Pol. 2016; 74(7): 691–696.
  66. Moon SJ, Lee WY, Hwang JS, et al. Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS One. 2017; 12(11): e0187139.
  67. Pogosova N, Kotseva K, De Bacquer D, et al. EUROASPIRE Investigators. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Eur J Prev Cardiol. 2017; 24(13): 1371–1380.
  68. Mierzyńska A, Jurczak K, Piotrowicz R. Psychological interventions in cardiology — short-term motivational strategies. Archives of Psychiatry and Psychotherapy. 2017; 19(2): 15–24.
  69. Lichtman JH, Bigger JT, Blumenthal JA, et al. American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Epidemiology and Prevention, American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008; 118(17): 1768–1775.
  70. Piepoli MF, Abreu A, Albus C, et al. Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2020; 27(2): 181–205.
  71. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
  72. Mach F, Baigent C, Catapano AL, et al. ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1): 111–188.
  73. Nissen SE, Nicholls SJ, Sipahi I, et al. ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006; 295(13): 1556–1565.
  74. Cannon CP, Blazing MA, Giugliano RP, et al. IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015; 372(25): 2387–2397.
  75. Sabatine MS, Giugliano RP, Keech AC, et al. FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017; 376(18): 1713–1722.
  76. Schwartz GG, Steg PG, Szarek M, et al. ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018; 379(22): 2097–2107.
  77. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010; 363(23): 2211–2219.
  78. Wormser D, Kaptoge S, Di Angelantonio EE, et al. Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011; 377(9771): 1085–1095.
  79. Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res. 2016; 118(11): 1844–1855.
  80. O'Neil P, Birkenfeld A, McGowan B, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet. 2018; 392(10148): 637–649.
  81. Mirabelli M, Chiefari E, Caroleo P, et al. Long-term effectiveness of liraglutide for weight management and glycemic control in type 2 diabetes. Int J Environ Res Public Health. 2019; 17(1): 207.
  82. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
  83. Zinman B, Wanner C, Lachin JM, et al. EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015; 373(22): 2117–2128.
  84. Wiviott SD, Raz I, Bonaca MP, et al. DECLARE–TIMI 58 Investigators. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019; 380(4): 347–357.
  85. Marso SP, Daniels GH, Brown-Frandsen K, et al. LEADER Steering Committee, LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016; 375(4): 311–322.
  86. Husain M, Birkenfeld AL, Donsmark M, et al. PIONEER 6 Investigators. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2019; 381(9): 841–851.
  87. Zelniker TA, Wiviott SD, Raz I, et al. Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation. 2019; 139(17): 2022–2031.
  88. Cosentino F, Grant PJ, Aboyans V, et al. ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020; 41(2): 255–323.
  89. Chow CK, Jolly S, Rao-Melacini P, et al. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010; 121(6): 750–758.
  90. Cahill K, Stevens S, Perera R, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013(5): CD009329.
  91. Malas M, van der Tempel J, Schwartz R, et al. Electronic cigarettes for smoking cessation: a systematic review. Nicotine Tob Res. 2016; 18(10): 1926–1936.
  92. Ghosh S, Drummond MB. Electronic cigarettes as smoking cessation tool: are we there? Curr Opin Pulm Med. 2017; 23(2): 111–116.
  93. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997; 315(7114): 973–980.
  94. DiGiacomo SI, Jazayeri MA, Barua RS, et al. Environmental tobacco smoke and cardiovascular disease. Int J Environ Res Public Health. 2018; 16(1): 96.
  95. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008; 35(2): 158–176.
  96. Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018; 72(25): 3332–3365.
  97. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011; 40(5): 1382–1400.
  98. Talbot LA, Morrell CH, Fleg JL, et al. Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging. Prev Med. 2007; 45(2-3): 169–176.
  99. Piepoli MF, Davos C, Francis DP, et al. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004; 328(7433): 189.
  100. Young DR, Hivert MF, Alhassan S, et al. Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation. 2016; 134(13): e262–e279.
  101. Fletcher GF, Ades PA, Kligfield P, et al. American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013; 128(8): 873–934.
  102. Bruning RS, Sturek M. Benefits of exercise training on coronary blood flow in coronary artery disease patients. Prog Cardiovasc Dis. 2015; 57(5): 443–453.
  103. Huffman JC, Niazi SK, Rundell JR, et al. Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee. Psychosomatics. 2014; 55(2): 109–122.
  104. Bishop GD, Kaur D, Tan VLM, et al. Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting. Am Heart J. 2005; 150(3): 602–609.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl